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more, RNA was isolated to evaluate the response to ALK5 or
ALK1 signaling on expression of aggrecan, collagen type II and
MMP-13.
In addition, knee joints were isolated from mice aged 1 or 2
years, OA prone STR/ort mice (aged 3, 6 and 9 months and
1 year) and mice in which OA was induced by destabilizing
the medial meniscus (DMM model). Immunohistochemistry for
ALK5 and ALK1 was performed and the number of cells staining
positive for each receptor in tibial cartilage was measured with a
computerized imaging system.
Results: TGF-beta signaled in chondrocytes both via Smad2/3
and Smad1/5/8. Transfection of chondrocytes with caALK5
speciﬁcally led to Smad2/3 phosphorylation, whereas caALK1
speciﬁcally led to Smad1/5/8 phosphorylation. Chondrocytes
that over expressed caALK5 showed enhanced aggrecan ex-
pression and slightly reduced collagen type II expression. Chon-
drocytes over expressing caALK1 had elevated expression of
aggrecan, collagen type II and MMP-13, thereby displaying an
OA-phenotype.
From 1 year old to 2 year old mice ALK5 decreased 88% in the
medial tibial cartilage and 76% in the lateral tibial cartilage. ALK1
also was reduced, but only 51% in the medial tibial cartilage and
33% on the lateral side. In the DMM model no change was
observed on the lateral side, but a reduction of 91% ALK5
positive cells compared to 75% ALK1 positive cells in the OA
developing medial side. In the STR/ort model, the number of
cells staining positive for ALK5 was already reduced to 7% in the
medial tibial cartilage by 3 months of age. This rapidly declined
to less than 1% by 9 months. On the lateral side there was
still abundant ALK5 expression at 3 months of age, however,
this rapidly decreases in time to less than 10% by 9 months
and 1 year of age. ALK1 expression however, although slightly
decreased stayed relatively high and even increased again by 1
year of age compared to 9 months of age.
Overall a signiﬁcant increase in the ALK1/ALK5 ratio with age
and OA progression was demonstrated.
Conclusions: Our data show that ALK1 over expression in
chondrocytes induced an OA-like phenotype in chondrocytes.
Moreover, a clear switch of chondrocyte ALK5 to ALK1 expres-
sion was associated with ageing and OA progression. Our data
suggest a role for ALK1 in deviant chondrocyte behavior during
ageing and OA development.
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THE IGF-1 SIGNALING INHIBITOR TRB3 IS INCREASED
IN OA CHONDROCYTES
J.D. Cravero1, C.S. Carlson2, R.F. Loeser1
1Wake Forest University School of Medicine, Winston Salem,
NC; 2University of Minnesota, St. Paul, MN
Purpose: The chondrocyte response to IGF-1 is reduced with
aging and in the development of OA, however, the mechanism
is not completely known. Activation of the PI3K/Akt pathway
is required for IGF-1 stimulation of proteoglycan synthesis and
likely also plays a role in survival signaling. Recently it has been
shown that TRB3, a tribbles homolog, inhibits IGF-1 activation of
Akt in HEK293 cells. The aim of this study was to determine if
a)TRB3 is expressed in chondrocytes and b) if it plays a role in
the reduced response to IGF-1 with aging or OA.
Methods: Adult human articular cartilage was obtained from
tissue donors (ages 19 to 83 graded on a 0-4 scale for degen-
erative changes) or from OA tissue removed at the time of joint
replacement. Proteins were either extracted directly from frozen,
pulverized tissue or chondrocytes were isolated from fresh tissue
by enzymatic digestion and cultured in high density monolayers.
Expression of TRB3 was analyzed by RT-PCR, immunoblotting,
and immunohistochemistry. Chondrocytes were transfected with
a TRB3 expression construct and the effects on cell survival
were determined in alginate beads at low density in serum-free
media (conditions in which the PI3K/Akt pathway is required for
survival).
Results: RT-PCR revealed that TRB3 is expressed in human
chondrocytes and the expression appeared to increase with
age. Immunoblotting of cartilage extracts could not conﬁrm an
age-related increase in TRB3 protein in normal tissue, however,
TRB3 protein levels were signiﬁcantly increased in chondrocytes
isolated from OA cartilage when compared to age-matched nor-
mal tissue. Likewise, TRB3 was detected in OA but not normal
tissue by immunohistochemistry. Overexpression of TRB3 in nor-
mal chondrocytes by transfection reduced survival by almost
50% when compared to cells transfected with an RFP control
plasmid. Overexpression of Akt in cells co-transfected with TRB3
was able to return survival back to control levels.
Conclusions: These results are the ﬁrst to demonstrate that
TRB3 is present in human OA cartilage and in isolated OA
chondrocytes. TRB3 has previously been shown to inhibit acti-
vation of Akt in response to IGF-1 and in the present studies
overexpression of TRB3 resulted in increased cell death. Thus,
TRB3 could play a role in the increased cell death noted in OA
cartilage. Further studies are examining if TRB3 also contributes
to reduced proteoglycan synthesis in response to IGF-I.
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Purpose: To examine the relationship between osteoarthritis
(OA), muscle quality, and peripheral nerve function in the context
of a normative aging study.
Methods: Data from 184 participants (87 women and 97 men) of
a normative aging cohort study were analyzed. Participants were
categorized as OA or no OA based on self-reported osteoarthritis
of the knee or hip. Persistent and recent knee and hip symptoms
were assessed by validated questionnaires. Participants also
underwent a standardized exam for presence of abnormalities
of the knee and hip. Ten millimeter computed tomography (CT)
axial images of the right middle tibia and the middle thigh were
obtained and analyzed for whole fat density, muscle density, and
cross-sectional area (CSA) (Geanie software, version 2.1). Fat
mass and lean mass of the right leg were also measured by dual
energy x-ray absorptiometry. The right peroneal nerve conduc-
tion velocity (NCV) was measured at the popliteal fossa and the
ﬁbular head. Data was analyzed using SPSS software. Differ-
ences between groups were tested by ANCOVA for continuous
variables and chi-square for categorical variables. The relation-
ships between OA and muscle quality were further analyzed
using stepwise ANCOVA analyses that included age, sex, race,
height2, smoking, alcohol consumption, comorbidities, physical
activity, and peripheral nerve function as independent variables.
Results: Data from 58 participants with self-reported knee or
hip OA and 126 without OA were analyzed. As shown in Table
1, participants with OA were older (p=0.004) compared to those
without OA, and had proportionately higher percentages of indi-
viduals with current knee or hip pain (p<0.001) and knee or hip
pain on examination (p=0.001). The proportion of females and
the average BMI were similar between the two groups. Muscle
density of the middle tibia was signiﬁcantly lower in individuals
with self-reported knee or hip OA (Figure 1; p=0.004). This rela-
tionship persisted after adjustment for age, self-reported recent
knee and/or hip pain, knee and/or hip pain upon examination, and
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No OA (N=126) OA (N=58) p-value
Age (Years) 67.2±1.29 72.6±1.32 0.004
Gender (M/F) 68/58 29/29 0.616
BMI (kg/m2) 27.1±0.421 27.7±0.603 0.441
Current Knee or Hip Pain N (%) 11 (8.7%) 19 (32.8%) <0.001
Knee or Hip Pain on Examination N (%) 25 (19.8%) 26 (44.8%) 0.001
Lean Mass of Right Leg by DXA (kg) (N=175) 15.6±3.62 15.2±3.48 0.433
Fat Mass of Right Leg by DXA (kg) (N=175) 4.48±1.80 4.77±2.29 0.356
Peroneal Nerve Conduction Velocity (m/s) 46.0±0.579 44.8±0.791 0.244
Figure 1. Average muscle density by OA status.
peripheral nerve function, but was substantially attenuated after
adjusting for total physical activity. Muscle density of the middle
thigh was signiﬁcantly lower in individuals with self-reported knee
or hip OA (p=0.014), but this relationship was fully explained by
the confounding effect of age (p=0.241). Peroneal nerve conduc-
tion velocity was not signiﬁcantly different between individuals
with self-reported OA and those without OA (p>0.05). Muscle
CSA, fat density, and lean and fat mass did not differ between
participants with self-reported OA compared to those without OA
(Table 1).
Conclusions: OA appears to be associated with lower middle
tibia muscle density, but not with changes in lean or fat mass. The
etiology and functional implications of lower muscle density in OA
are currently being evaluated. This study was fully supported by
the Intramural Research Program (IRP) of the National Institutes
of Health,-National Institute on Aging (NIA).
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TARGETED DISRUPTION AND AGING-RELATED LOSS
OF THE CARTILAGE SURFACE-SPECIFIC PROTEIN
HMGB2 LEADS TO EARLY ONSET OSTEOARTHRITIS
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Purpose: Osteoarthritis (OA) typically begins with an aging-
related disruption of the articular cartilage surface, followed by
progressive destruction and loss of cartilage. Mechanisms lead-
ing to the aging-related surface degeneration remain to be deter-
mined. In this study we demonstrate that the chromatin protein
HMGB2 is uniquely expressed in chondrocytes in the superﬁcial
zone of articular cartilage and determine the impact of Hmgb2
deﬁciency on cartilage homeostasis and OA pathogenesis.
Methods: Immunostaining was used to assess HMGB2 expres-
sion in human articular cartilage from younger (17-39 y.o.) and
older (61-85 y.o.) donors (N=6); and in C57Bl/6J mouse knee
joints at 3, 6, 9 and 15 months of age (N=6), respectively. Using
adult Hmgb2-/- mice at 3, 6, 9, 12 months old, knee joints were
examined by safranin O staining and OA grades were evalu-
ated by Mankin scoring. Cell death in articular cartilage was
examined by immunohistochemistry for apoptosis markers active
caspase-3 and parp-p85 and compared with the matrix degra-
dation markers MMP-3 and MMP-13. Superﬁcial zone protein
(SZP) in murine joints was examined by in situ hybridization.
Results: In normal human and murine knee articular cartilage
HMGB2 is exclusively expressed in the superﬁcial zone. In both
species there is an aging-related decline in HMGB2 expression,
ultimately leading to its complete absence and this is associated
with the development of structural lesions in the cartilage sur-
face. Mice with a targeted disruption of the HMGB2 gene have
normal development of the skeleton and joints. However, HMGB2
deﬁcient mice show early onset of osteoarthritis joint pathology.
In Hmgb2-/- mice there is increased parp-p85 at 6 months as-
sociated with a reduction in cellularity. MMP-3 is increased in
Hmgb2-/- at 6 months and reduced at 9 months while MMP-13 is
strongly expressed at 9 months. In Hmgb2-/- mice there is also
a reduction and early loss of SZP.
Conclusions: These ﬁndings identify HMGB2 as a factor specif-
ically expressed in superﬁcial zone chondrocytes and required
for cell survival and cartilage homeostasis. The aging-associated
loss of HMGB2 may be a novel trigger for the onset of OA.
The HMGB2 deﬁcient mouse represents a novel OA model that
recapitulates central features of the human disease.
